Albumin
Albumin is the principal soluble protein in human plasma, synthesized mainly by the liver.
Albumin is the principal soluble protein in human plasma, synthesized mainly by the liver. It helps maintain plasma colloid osmotic pressure and transports a range of endogenous and exogenous substances, including fatty acids, hormones, metabolites, and some medicines. Serum albumin concentration is therefore influenced by hepatic synthesis, nutritional and inflammatory states, fluid balance, and protein loss, and is commonly interpreted as a clinical marker rather than as an isolated measure of nutritional status.
In the literature represented here, albumin is used in nutritional, inflammatory, renal, infectious, and oncological risk assessment. It contributes to composite measures such as the albumin-derived neutrophil-to-lymphocyte ratio, geriatric nutritional risk index, prognostic nutritional index, and C-reactive protein/albumin ratio, and is incorporated with body mass index, hemoglobin, creatinine, C-reactive protein, and neutrophil-to-lymphocyte ratio in prognostic or predictive models. Reported applications include associations with survival in colorectal cancer, oral squamous cell carcinoma, lymphoma, and extensive-stage small-cell lung cancer; renal progression in type 2 diabetes; infection risk in systemic lupus erythematosus; and clinical outcomes in ulcerative colitis. Albumin-to-creatinine ratio is a related urinary measure used to assess albumin excretion and its relationship to glycemic control, and should be distinguished from the serum albumin concentration.
Where the papers sit
9 papers from the last 6 months study albumin directly · updated from PubMed 10 Nov 2026
Study type 0 clinical trials · 5 observational · 2 human data · 1 preclinical · 1 unclassified
Themes one subject
Those 9 are all about one subject.
-
Albumin-Based Clinical Risk Assessment
Albumin-associated ratios, nutritional indices, and clinical models are being used to stratify prognosis and complications across cancer, diabetes, infection, and inflammatory disease. Recurring measures include albumin-derived neutrophil-to-lymphocyte ratio, albumin-creatinine ratio, CRP/albumin ratio, CTI, and geriatric nutritional risk index. These markers support survival prediction, renal-risk assessment, glycemic evaluation, and explainable machine-learning models, but remain largely prognostic rather than mechanistic. Albumin-based carriers also point toward therapeutic delivery, linking risk measurement with broader clinical applications.
Papers
The 9 papers from the last 6 months that study albumin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Albumin-Based Clinical Risk Assessment (9)
- Preoperative Albumin-derived Neutrophil-to-Lymphocyte Ratio Predicts Survival Across Pathological Stages of Colorectal Cancer. Anticancer research · 27 Oct 2026 PMID 42946421
- Factors associated with poor glycemic control and its correlation with albumin creatinine ratio among patients with type 2 diabetes mellitus at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. PloS one · 5 Oct 2026 PMID 42832509
- Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model. Biomarker research · 17 Sept 2026 PMID 42750067
- Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
- Enhanced transendothelial delivery of albumin-based carriers into tumors via macropinocytosis. Journal of controlled release : official journal of the Controlled Release Society · 24 Aug 2026 PMID 42636894
- An explainable machine learning model for predicting in-hospital infection in patients with systemic lupus erythematosus. Renal failure · 5 Aug 2026 PMID 42557059
- A study on risk factors for the progression from T2DM to end-stage renal disease based on Mendelian randomization and logistic regression analysis. Renal failure · 5 Aug 2026 PMID 42556871
- Real-World Prognostic Analysis of Clinical Characteristics in Extensive-Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First-Line Immunochemotherapy With Serplulimab. Cancer medicine · 30 Jul 2026 PMID 42533271
- C-reactive protein/albumin ratio as a potential inflammatory marker for predicting clinical outcomes in patients with moderate to severe ulcerative colitis: A retrospective study. Medicine · 25 Jul 2026 PMID 42499090
By study type
Observational studies and case reports (5)
- Preoperative Albumin-derived Neutrophil-to-Lymphocyte Ratio Predicts Survival Across Pathological Stages of Colorectal Cancer. Anticancer research · 27 Oct 2026 PMID 42946421
- Factors associated with poor glycemic control and its correlation with albumin creatinine ratio among patients with type 2 diabetes mellitus at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. PloS one · 5 Oct 2026 PMID 42832509
- A study on risk factors for the progression from T2DM to end-stage renal disease based on Mendelian randomization and logistic regression analysis. Renal failure · 5 Aug 2026 PMID 42556871
- Real-World Prognostic Analysis of Clinical Characteristics in Extensive-Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First-Line Immunochemotherapy With Serplulimab. Cancer medicine · 30 Jul 2026 PMID 42533271
- C-reactive protein/albumin ratio as a potential inflammatory marker for predicting clinical outcomes in patients with moderate to severe ulcerative colitis: A retrospective study. Medicine · 25 Jul 2026 PMID 42499090
Human data, design not indexed (2)
- Pretreatment Geriatric Nutritional Risk Index in RADPLAT-treated Patients With Oral Squamous Cell Carcinoma: A Pilot Study. In vivo (Athens, Greece) · 28 Aug 2026 PMID 42665408
- An explainable machine learning model for predicting in-hospital infection in patients with systemic lupus erythematosus. Renal failure · 5 Aug 2026 PMID 42557059
Preclinical: animal, cell and lab studies (1)
- Enhanced transendothelial delivery of albumin-based carriers into tumors via macropinocytosis. Journal of controlled release : official journal of the Controlled Release Society · 24 Aug 2026 PMID 42636894
Unclassified: not yet indexed with MeSH (1)
- Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model. Biomarker research · 17 Sept 2026 PMID 42750067
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-11-02. Drafted by language models from published abstracts; not medical advice.